Evidence map›Paper›PMID 39254064›Full record

ArticleEuropean journal of neurology2024

Microstructure of the cerebellum and its afferent pathways underpins dystonia in myoclonus dystonia.

Clément Tarrano, Giuseppe Zito, Cécile Galléa, Cécile Delorme, Eavan M McGovern, Cyril Atkinson-Clement, Vanessa Brochard, Stéphane Thobois, Christine Tranchant, David Grabli and 13 more

Abstract read
In one paragraph

Article in European journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Distinct Brain Drivers and Shared Cerebello-Cortical Input in ADCY5 and SGCE Hyperkinetic Movements.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Sex-specific alterations of Purkinje cell firing inDystonia (Lausanne, Switzerland) · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Clément TarranoParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.ORCID 0000-0001-5627-2126
Giuseppe ZitoSwiss Paraplegic Research, Nottwil, Switzerland.
Cécile GalléaParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.
Cécile DelormeParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.
Eavan M McGovernDepartment of Neurology, Beaumont Hospital, Dublin, Ireland.
Cyril Atkinson-ClementParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.ORCID 0000-0001-9499-3485
Vanessa BrochardDepartment of Neurology, Clinical Investigation Center for Neurosciences, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France.
Stéphane ThoboisNeurological Department C, Hopital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Christine TranchantDépartement de Neurologie, Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre, Strasbourg, France.
David GrabliParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.
Bertrand DegosDepartment of Neurology, Assistance Publique-Hôpitaux de Paris, Avicenne Hospital, Sorbonne Paris Nord, Bobigny, France.
Jean Christophe CorvolParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.
Jean-Michel PedespanDepartment of Neuropediatry, University Hospital of Pellegrin, Bordeaux, France.
Pierre KrystkowiakAbu Dhabi Stem Cells Center, Abu Dhabi, UAE.
Jean-Luc HouetoDepartment of Neurology, Centre Hospitalier Universitaire de Limoges, INSERM U1094, IRD U270, Epidemiology of Chronic Diseases in Tropical Zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, University of Limoges, Limoges, France.
Adrian DegardinDepartment of Neurology, Tourcoing Hospital, Tourcoing, France.
Luc DefebvreCentre Hospitalier Universitaire de Lille, INSERM U1172, Troubles Cognitifs Dégénératifs et Vasculaires, University of Lille, Lille, France.
Mélanie DidierParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.
Romain ValabrègueParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.
Emmanuelle ApartisParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.
Marie VidailhetParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.
Emmanuel RozeParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.
Yulia WorbeParis Brain Institute, INSERM, CNRS, Sorbonne Université, Paris, France.ORCID 0000-0001-5903-9370

Funding

AmadysDystonia Medical Research FoundationEuropean Union's Horizon 2020 research and innovation programme under the European Joint Programme on Rare Diseases (EJP RD) COFUND-EJP No. 825575-EurDyscoverFondation pour la Recherche Médicale
6 · The paper itself

Abstract

background and purposeMyoclonus dystonia due to a pathogenic variant in SGCE (MYC/DYT-SGCE) is a rare condition involving a motor phenotype associating myoclonus and dystonia. Dysfunction within the networks relying on the cortex, cerebellum, and basal ganglia was presumed to underpin the clinical manifestations. However, the microarchitectural abnormalities within these structures and related pathways are unknown. Here, we investigated the microarchitectural brain abnormalities related to the motor phenotype in MYC/DYT-SGCE.

methodsWe used neurite orientation dispersion and density imaging, a multicompartment tissue model of diffusion neuroimaging, to compare microarchitectural neurite organization in MYC/DYT-SGCE patients and healthy volunteers (HVs). Neurite density index (NDI), orientation dispersion index (ODI), and isotropic volume fraction (ISOVF) were derived and correlated with the severity of motor symptoms. Fractional anisotropy (FA) and mean diffusivity (MD) derived from the diffusion tensor approach were also analyzed. In addition, we studied the pathways that correlated with motor symptom severity using tractography analysis.

resultsEighteen MYC/DYT-SGCE patients and 24 HVs were analyzed. MYC/DYT-SGCE patients showed an increase of ODI and a decrease of FA within their motor cerebellum. More severe dystonia was associated with lower ODI and NDI and higher FA within motor cerebellar cortex, as well as with lower NDI and higher ISOVF and MD within the corticopontocerebellar and spinocerebellar pathways. No association was found between myoclonus severity and diffusion parameters.

conclusionsIn MYC/DYT-SGCE, we found microstructural reorganization of the motor cerebellum. Structural change in the cerebellar afferent pathways that relay inputs from the spinal cord and the cerebral cortex were specifically associated with the severity of dystonia.

Indexed as

Afferent PathwaysCerebellumDystonic DisordersAdultDiffusion Tensor ImagingFemaleHumansMaleMiddle AgedSarcoglycansYoung AdultSarcoglycansSGCE protein, humancerebellumdiffusion tensor imagingdystoniamyoclonusneuroimaging

Identifiers

PMID39254064
PMCPMC11555160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.